about
HIV-Host Interactions: Implications for Vaccine DesignA New Scientific Paradigm may be Needed to Finally Develop an HIV VaccineUsing nonhuman primates to model HIV transmissionThe Antibody Response against HIV-1Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionSuppression of APOBEC3-mediated restriction of HIV-1 by VifTracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmissionHIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.Factors determining human-to-human transmissibility of zoonotic pathogens via contactThe genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary ratesCCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infectionCellular superspreaders: an epidemiological perspective on HIV infection inside the bodySurvivors Remorse: antibody-mediated protection against HIV-1.Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.Why primate models matter.HIV pathogenesis: dynamics and genetics of viral populations and infected cells.Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primatesAntiviral natural products and herbal medicines.Simultaneous inference of phylogenetic and transmission trees in infectious disease outbreaks.Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr SequencesCulture and identification of Borrelia spirochetes in human vaginal and seminal secretions.HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesFcgbp - A Potential Viral Trap in RV144Phenotypic properties of transmitted founder HIV-1Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells.Particle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloningNatural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.The T-cell response to HIV.Analysis of Bottlenecks in Experimental Models of Infection.HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck.High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmissionTransmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus InfectionHIV prevention by oral preexposure prophylaxis.An HIV Vaccine for South-East Asia-Opportunities and Challenges.Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study.Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.New prospects for a preventive HIV-1 vaccine.
P2860
Q26765966-E656AF9B-EA8F-4CE2-8459-D10B961B4D55Q26830360-34A36E53-2A46-4612-99CB-C6FAC2F09E63Q26861425-F72BB6F2-6EA3-46F5-9651-CC850FE9719FQ27000889-8746609D-47EE-45EF-AE81-0B3C98872D14Q27004059-916434C4-2D54-4531-AFE7-0348B85F2E39Q27025150-72183723-31B0-45D3-804D-E207C2295713Q27313356-0F6330AA-D07F-40DA-B004-F78A1E9AA122Q27687375-FCF89600-E48D-419F-AAC0-6945519B96B2Q28073931-CFDDF3C7-669F-40D5-82AE-C9313ADF7126Q28541827-626BEFE1-6F1D-4D06-8114-8D8937692DE7Q28542878-2D7D5C63-5F05-417B-9EC5-685ED6FE818DQ28657772-3F821A1E-1A7C-4B78-B55A-E7E4A3BA55C2Q30238730-3DBA5C7E-B2BE-4AE1-9597-5F300FA60BD4Q30360888-C885579E-DEC1-4F9D-8062-BAA85D757FFDQ30417520-AC4FDD69-4ED5-4AD2-B5B6-5D29DA9EE337Q30425443-F0C7F2FB-7D46-44C7-8F60-B60E48B41303Q33355730-9993CF2F-4815-4FDE-B628-AF01715B60EDQ33657624-04E64404-3A9C-4912-8A89-78C74ED35D18Q33703514-F14AD9E8-8F52-4D1F-9C6C-922E0DBE0339Q33768060-76C9E788-E61C-4397-AA50-28080AE29E1AQ33828584-00707694-E159-412E-9614-818F6DE0A0F8Q33900395-94D68092-97C6-4DD8-AD0E-6009F5FB3FB2Q34057711-980CB9BE-0B63-4444-8D1A-92EB05F3F4F6Q34201287-B04715D2-71CC-4A33-868E-05D30D86C3F6Q34336058-64026C15-68A5-4D39-8443-74C544CAE823Q34385257-23A554A6-FA6A-4F06-9A62-BEA61997B569Q34614272-AC5A7F50-9F38-455E-9112-F62111E3919FQ34625185-65CCA35C-325B-4DF8-8C9D-1C7ECF1E98CFQ34642996-DBCBB5FB-5AD9-448F-A4D7-2F78BC8BE253Q34670588-B4F10F14-3754-419E-87BA-584C0F2865B9Q34906292-D50858C9-9BE8-43A4-97DD-2E596E9BB432Q35188022-A3FEEC23-DD01-4218-AFEF-A37B0967A13DQ35330357-295866DA-745A-48FE-AF20-500B7815BD79Q35488153-1E26B90A-639D-4434-9433-A1F3E67DB438Q35641523-9A507809-D983-445D-A24C-F874C8699EB7Q35765743-14F9728C-6978-450A-8620-94481B439E6FQ35826681-390C59C0-BDF8-41D5-B810-25547A221E3EQ35850177-6B7BED50-4060-4AFB-8E73-A32FE861336DQ35914362-0870AB6D-875F-484C-A5B8-A3F51AFBF043Q36223864-20E92132-6454-433B-8E2A-912BCF3519B5
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HIV transmission
@ast
HIV transmission
@en
type
label
HIV transmission
@ast
HIV transmission
@en
prefLabel
HIV transmission
@ast
HIV transmission
@en
P2860
P1476
HIV transmission
@en
P2093
Eric Hunter
P2860
P356
10.1101/CSHPERSPECT.A006965
P577
2012-11-01T00:00:00Z